Safety of Newborn infants Threatened by Rx antidepressants during pregnancy
"During a hastily called press conference yesterday,” the FDA announced that it is considering ADDITIONAL warnings on the labels of SSRI drugs—Prozac, Paxil, Zoloft, et al.
U.S. Subpoena Opens a New Front in Investigation ofGuidant Heart Devices
"The subpoena shows that the government is investigating Guidant for possible violations of health care statutes
If the auto industry operated like Big Pharma
Your average car would cost $4.5 million, representing a 30,000% markup over cost, which is typical for prescription drugs.
“this was a drug bill written by and for lobbyists”
Two items in today’s New York Times illustrate the contrast between what the Administration claims it’s legislative / regulatory proposals will do for health care, and what they actually do after they’ve taken effect.
FDA: NIMH SSRI Study Flawed–No Comparative Untreated Group
Even Dr. Robet Temple, FDA Medical Policy Director of the Center for Drug Evaluation & Research dismisses the claimed finidings of a flawed, but highly trumpeted recent SSRI study published in the American Journal of Psychiatry. The study was sponsored by the National Institute of Mental Health.
Comments Re:13 year BMJ investigation of research misconduct
Responding to the AHRP Infomail–Medical Journal Editor Finds Truth Hard to
Track Down (December 27) Eddie Vos,* expert nutrition specialist offers
comments about the13-year ‘"investigation" of alleged research misconduct by
an Indian physician, as reported in the Wall Street Journal (December 27).
National Plan for Universal Mental Health Screening:A Pharma Friendly Remedy for Societal Problems
Download the complete powerpoint presentation
Text of power point presentation:
Slide 2: I’ll begin with the President’s New Freedom Commission on Mental Health[1] recommendation to screen the US population for mental illness – 52 million children first. In no other democratic country has the government adopted a policy to screen the population for presumed, undetected, mental illness. The rationale behind this mind-boggling Orwellian nightmare is not improving mental health, but rather increasing life-long consumers of psychoactive drugs and to control behavior. Two NFC recommendations are designed to do just that. TeenScreen is promoted as a suicide prevention model when it in fact, increases the number of children labeled suicidal and depressed.
Gov Accountability Project Creates "FactSquad" on Rx Drugs
Gov Accountability Project Creates “FactSquad” on Rx Drugs December 11, 2005 In the wake of the credibility crisis public trust in the safety of FDA-approved prescription drugs is eroded. The Government Accounability Project (GAP) has established a “Fact Squad” to challenge poor performance; in particular, FDA’s failure to protect the…
College Students Abuse of psychostimulants–Adderall / concerta / Ritalin
College Students Abuse of psychostimulants–Adderall / concerta / Ritalin Fri, 5 Aug 2005 The abuse of Ritalin and other prescribed amphetamine-like psychostimulant drugs by college students is spiralling as students have grown accustomed to rely on pills as a crutch for coping with pressure. Andrew Jacobs of the New York…
Lucrative Drug, Danger Signals and the F.D.A. – NY Times
http://www.nytimes.com/2005/06/10/business/10drug.html?ei=5094&en=5475b3c17e50e692&hp =&ex=1118462400&partner=homepage&pagewanted=print THE NEW YORK TIMES June 10, 2005, front page Lucrative Drug, Danger Signals and the F.D.A. By GARDINER HARRIS and ERIC KOLI Dozens had died and more than 100 patients had suffered serious heart problems by March 1998 after taking Propulsid, a popular medicine for heartburn. Infants, given…
TeenScreen: the Law Suits Begin
TeenScreen: the Law Suits Begin Mon, 13 Jun 2005 Newsworthy developments about the duo-drug promotion scam‹TeenScreen & TMAP: A. The first legal challenge against TeenScreen, the mental health screening scheme that is invading the public school system across the nation, declaring otherwise normal children to be mentally ill, has been…
"Lilly is Hiding Negative Information About Zyprexa" – SAPS
“Lilly is Hiding Negative Information About Zyprexa” – SAPS Wed, 2 Nov 2005 From our colleague in Sweden: A published interview with Dr. Curt Furberg, Professor of Public Health Sciences Wake Forest University Baptist Medical Center, and Chair, Steering Committee, and Principal Investigator, of one of the most important studies…